Fredag 4. juli 2025
Longship Fund III invests in NordicNeuroLab, a global leader in advanced MRI solutions
Longship Fund III («Longship») has acquired a majority stake in Nordiclabs AS (“NordicNeuroLab”), a Norwegian medical technology company. The investment represents a new platform acquisition for Longship Fund III. The current management team will stay on as minority investors.
NordicNeuroLab is a globally recognized provider of equipment and software for functional magnetic resonance imaging (“fMRI”). With a customer base spanning over 70 countries, the company serves leading hospitals, imaging centers, and research institutions worldwide. NordicNeuroLab is regarded as a pioneer within fMRI, offering a unique combination of MRI-compatible hardware, comfort solutions, and advanced neuroimaging software.
The company’s newly launched SaaS platform, nordicMEDiVA, enables automated and standardized analysis of brain imaging data, addressing key needs in clinical diagnostics and research. NordicNeuroLab’s products are used for brain mapping, surgical planning, and evaluation of neurological conditions, and are distributed both directly and through global OEM partnerships.
“NordicNeuroLab has built a world-class position in clinical and research-driven brain imaging,” says Kai Jordahl, Partner at Longship. “We are impressed by the company’s strong international presence, technical depth, and reputation among clinicians and researchers. We look forward to supporting the team on their continued journey.”
Thomas Omdahl, CEO of NordicNeuroLab, comments: “We have spent over 20 years developing solutions that enhance clinical precision, improve patient comfort, and streamline workflows for radiologists and clinicians. With Longship onboard, we gain a committed partner to support the next phase of our journey. Together, we aim to scale NordicNeuroLab into a world-leading medtech company within brain imaging and surgical planning.”
The transaction was completed in July 2025 and marks the fifth platform investment in Longship Fund III.
Longship was advised by Chartis, Schjødt, PwC, Acapo Onsagers and Advisense. NordicNeuroLab was advised by SAGA Corporate Finance and BAHR.
For more information, please contact:
Kai Jordahl, Partner, Longship AS
+47 909 82 271
kai.jordahl@longship.no
Thomas Omdahl, CEO, NordicNeuroLab AS
+47 924 72 324
thomas.omdahl@nordicneurolab.com
About Longship
Longship is a Norwegian private equity firm established by a group of experienced investment professionals in 2015. Longship invests in companies with significant growth potential in the Norwegian lower mid-market and is applying a transformational growth approach. Longship manages three funds with approx. NOK 5.2 billion in committed capital.
About NordicNeuroLab
NordicNeuroLab is a Bergen-based medical technology company and global provider of medical imaging equipment and software. The company delivers visualization systems, comfort solutions, and neuroimaging software used in clinical and research settings across more than 70 countries.
https://www.nordicneurolab.com/